Otonomy Analyst Ratings
Otonomy Analyst Ratings
While ratings are subjective and will change, the latest Otonomy (OTIC) rating was a downgraded with a price target of $3.00 to $0.50. The current price Otonomy (OTIC) is trading at is $0.12, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/13/2022 | 317.01% | Piper Sandler | $3 → $0.5 | Downgrades | Overweight → Neutral |
| 08/02/2022 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 04/21/2022 | 4904.17% | Oppenheimer | $5 → $6 | Maintains | Outperform |
| 02/23/2021 | 4487.16% | HC Wainwright & Co. | $10 → $5.5 | Maintains | Buy |
| 07/07/2020 | 7406.26% | HC Wainwright & Co. | $8 → $9 | Maintains | Buy |
| 06/16/2020 | 7406.26% | Cantor Fitzgerald | $3 → $9 | Maintains | Overweight |
| 12/24/2019 | 6572.23% | Oppenheimer | → $8 | Initiates Coverage On | → Outperform |
| 08/29/2019 | 6572.23% | HC Wainwright & Co. | → $8 | Initiates Coverage On | → Buy |
| 11/15/2018 | 7406.26% | Cantor Fitzgerald | → $9 | Initiates Coverage On | → Overweight |
| 03/19/2018 | — | JP Morgan | Downgrades | Neutral → Underweight |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 2022 年 10 月 13 日 | 317.01% | 派珀·桑德勒 | 3 美元 → 0.5 美元 | 降级 | 超重 → 中性 |
| 08/02/2022 | — | HC Wainwright & Co. | 降级 | 买入 → 中性 | |
| 04/21/2022 | 4904.17% | 奥本海默 | 5 美元 → 6 美元 | 维护 | 跑赢大盘 |
| 2021 年 2 月 23 日 | 4487.16% | HC Wainwright & Co. | 10 美元 → 5.5 美元 | 维护 | 买 |
| 07/07/2020 | 7406.26% | HC Wainwright & Co. | 8 美元 → 9 美元 | 维护 | 买 |
| 06/16/2020 | 7406.26% | 坎托·菲茨杰拉德 | 3 美元 → 9 美元 | 维护 | 超重 |
| 12/24/2019 | 6572.23% | 奥本海默 | → 8 美元 | 启动覆盖范围开启 | → 跑赢大盘 |
| 2019 年 8 月 29 日 | 6572.23% | HC Wainwright & Co. | → 8 美元 | 启动覆盖范围开启 | → 购买 |
| 11/15/2018 | 7406.26% | 坎托·菲茨杰拉德 | → 9 美元 | 启动覆盖范围开启 | → 超重 |
| 2018 年 3 月 19 日 | — | 摩根大通 | 降级 | 中性 → 体重不足 |
Otonomy Questions & Answers
Otonomy 问题与解答
The latest price target for Otonomy (NASDAQ: OTIC) was reported by Piper Sandler on October 13, 2022. The analyst firm set a price target for $0.50 expecting OTIC to rise to within 12 months (a possible 317.01% upside). 3 analyst firms have reported ratings in the last year.
派珀·桑德勒于2022年10月13日公布了Otonomy（纳斯达克股票代码：OTIC）的最新目标股价。该分析公司将目标股价定为0.50美元，预计OTIC将在12个月内升至12个月内（可能上涨317.01％）。去年有3家分析公司公布了评级。
The latest analyst rating for Otonomy (NASDAQ: OTIC) was provided by Piper Sandler, and Otonomy downgraded their neutral rating.
派珀·桑德勒对Otonomy（纳斯达克股票代码：OTIC）的最新分析师评级由派珀·桑德勒提供，Otonomy下调了中性评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Otonomy, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Otonomy was filed on October 13, 2022 so you should expect the next rating to be made available sometime around October 13, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Otonomy的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Otonomy的最新评级是在2022年10月13日发布的，因此您应该预计下一个评级将在2023年10月13日左右公布。
While ratings are subjective and will change, the latest Otonomy (OTIC) rating was a downgraded with a price target of $3.00 to $0.50. The current price Otonomy (OTIC) is trading at is $0.12, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的Otonomy（OTIC）评级已下调，目标股价为3.00美元至0.50美元。Otonomy（OTIC）目前的交易价格为0.12美元，超出了分析师的预期区间。
